Extracellular Vesicles Derived from Mesenchymal Stromal Cells: a Therapeutic Option in Respiratory Diseases?

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2016 Apr 15

PMID 27075363

Citations 63

Authors

Soraia C Abreu

Daniel J Weiss

Patricia R M Rocco

Affiliations

Soon will be listed here.

Abstract

Extracellular vesicles (EVs) are plasma membrane-bound fragments released from several cell types, including mesenchymal stromal cells (MSCs), constitutively or under stimulation. EVs derived from MSCs and other cell types transfer molecules (such as DNA, proteins/peptides, mRNA, microRNA, and lipids) and/or organelles with reparative and anti-inflammatory properties to recipient cells. The paracrine anti-inflammatory effects promoted by MSC-derived EVs have attracted significant interest in the regenerative medicine field, including for potential use in lung injuries. In the present review, we describe the characteristics, biological activities, and mechanisms of action of MSC-derived EVs. We also review the therapeutic potential of EVs as reported in relevant preclinical models of acute and chronic respiratory diseases, such as pneumonia, acute respiratory distress syndrome, asthma, and pulmonary arterial hypertension. Finally, we discuss possible approaches for potentiating the therapeutic effects of MSC-derived EVs so as to enable use of this therapy in clinical practice.

Citing Articles

Exosomes derived from hypoxic mesenchymal stem cell ameliorate premature ovarian insufficiency by reducing mitochondrial oxidative stress.

Zhang S, Zou X, Feng X, Shi S, Zheng Y, Li Q Sci Rep. 2025; 15(1):8235.

PMID: 40065033 PMC: 11894067. DOI: 10.1038/s41598-025-90879-3.

From mesenchymal stem cells to their extracellular vesicles: Progress and prospects for asthma therapy.

Chen S, Gao J, Zhang T Asian J Pharm Sci. 2024; 19(4):100942.

PMID: 39253613 PMC: 11382190. DOI: 10.1016/j.ajps.2024.100942.

Efficacy of stem cells versus microvesicles in ameliorating chronic renal injury in rats (histological and biochemical study).

Mohammed M, Abdelrahman S, El-Shal A, Abdelrahman A, Hamdy M, Sarhan W Sci Rep. 2024; 14(1):16589.

PMID: 39025899 PMC: 11258134. DOI: 10.1038/s41598-024-66299-0.

Understanding molecular characteristics of extracellular vesicles derived from different types of mesenchymal stem cells for therapeutic translation.

Ding Z, Greenberg Z, Serafim M, Ali S, Jamieson J, Traktuev D Extracell Vesicle. 2024; 3.

PMID: 38957857 PMC: 11218754. DOI: 10.1016/j.vesic.2024.100034.

INDUCED PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELLS-DERIVED EXTRACELLULAR VESICLES ATTENUATE LPS-INDUCED LUNG INJURY AND ENDOTOXEMIA IN MICE.

Meng Q, Winston T, Ma J, Song Y, Wang C, Yang J Shock. 2024; 62(2):294-303.

PMID: 38813932 PMC: 11466509. DOI: 10.1097/SHK.0000000000002381.

References

DeMayo F, Minoo P, Plopper C, Schuger L, Shannon J, Torday J . Mesenchymal-epithelial interactions in lung development and repair: are modeling and remodeling the same process?. Am J Physiol Lung Cell Mol Physiol. 2002; 283(3):L510-7. DOI: 10.1152/ajplung.00144.2002. View

Chen J, Li C, Chen L . The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung Diseases. Biomed Res Int. 2015; 2015:985814. PMC: 4443645. DOI: 10.1155/2015/985814. View

Tian Y, Li S, Song J, Ji T, Zhu M, Anderson G . A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2013; 35(7):2383-90. DOI: 10.1016/j.biomaterials.2013.11.083. View

Almqvist N, Lonnqvist A, Hultkrantz S, Rask C, Telemo E . Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma. Immunology. 2008; 125(1):21-7. PMC: 2526256. DOI: 10.1111/j.1365-2567.2008.02812.x. View

Baglio S, Rooijers K, Koppers-Lalic D, Verweij F, Perez Lanzon M, Zini N . Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther. 2015; 6:127. PMC: 4529699. DOI: 10.1186/s13287-015-0116-z. View

Matthay M, Howard J . Progress in modelling acute lung injury in a pre-clinical mouse model. Eur Respir J. 2012; 39(5):1062-3. DOI: 10.1183/09031936.00204211. View

Baranova I, Kurlander R, Bocharov A, Vishnyakova T, Chen Z, Remaley A . Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J Immunol. 2008; 181(10):7147-56. PMC: 3842223. DOI: 10.4049/jimmunol.181.10.7147. View

Tomasoni S, Longaretti L, Rota C, Morigi M, Conti S, Gotti E . Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev. 2012; 22(5):772-80. PMC: 3578372. DOI: 10.1089/scd.2012.0266. View

Lee J, Fang X, Krasnodembskaya A, Howard J, Matthay M . Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells. 2011; 29(6):913-9. PMC: 3293251. DOI: 10.1002/stem.643. View

10.

Zhang B, Yin Y, Lai R, Tan S, Choo A, Lim S . Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev. 2013; 23(11):1233-44. DOI: 10.1089/scd.2013.0479. View

11.

Monsel A, Zhu Y, Gennai S, Hao Q, Hu S, Rouby J . Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice. Am J Respir Crit Care Med. 2015; 192(3):324-36. PMC: 4584251. DOI: 10.1164/rccm.201410-1765OC. View

12.

Sarkar A, Mitra S, Mehta S, Raices R, Wewers M . Monocyte derived microvesicles deliver a cell death message via encapsulated caspase-1. PLoS One. 2009; 4(9):e7140. PMC: 2744928. DOI: 10.1371/journal.pone.0007140. View

13.

Fujita Y, Kosaka N, Araya J, Kuwano K, Ochiya T . Extracellular vesicles in lung microenvironment and pathogenesis. Trends Mol Med. 2015; 21(9):533-42. DOI: 10.1016/j.molmed.2015.07.004. View

14.

Rubenfeld G, Caldwell E, Peabody E, Weaver J, Martin D, Neff M . Incidence and outcomes of acute lung injury. N Engl J Med. 2005; 353(16):1685-93. DOI: 10.1056/NEJMoa050333. View

15.

Lai R, Chen T, Lim S . Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med. 2011; 6(4):481-92. DOI: 10.2217/rme.11.35. View

16.

Katsuda T, Kosaka N, Takeshita F, Ochiya T . The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics. 2013; 13(10-11):1637-53. DOI: 10.1002/pmic.201200373. View

17.

Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P . Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia. 2006; 20(5):847-56. DOI: 10.1038/sj.leu.2404132. View

18.

Gyorgy B, Hung M, Breakefield X, Leonard J . Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu Rev Pharmacol Toxicol. 2014; 55:439-464. PMC: 4445965. DOI: 10.1146/annurev-pharmtox-010814-124630. View

19.

Zhao S, Wehner R, Bornhauser M, Wassmuth R, Bachmann M, Schmitz M . Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev. 2009; 19(5):607-14. DOI: 10.1089/scd.2009.0345. View

20.

Gould S, Raposo G . As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles. 2013; 2. PMC: 3760635. DOI: 10.3402/jev.v2i0.20389. View